Article
09 Oct 2025
生命科学行业License-in/out合同争议要点分析（三）：不竞争条款
RANKINGS
This author falls within the Top 20% for their listed topics and industry categories. Based on Mondaq users readership, this author is ranked as VERY POPULAR in China
AUTHORS CONTENT
Article
09 Oct 2025
2024 Data Analytics: China Life Sciences NewCo & Licensing Terms
Article
09 Oct 2025
Strengthening Oversight of Imported Drugs: Key Takeaways into New Regulations on Domestic Responsible Entities
Article
25 Sep 2025
Han Kun • Quick Comment | Is The Transmission Of Cross-border Genomic Data Between China And The United States Blocked? Biden Data Executive Order Quick Review
Article
24 Sep 2025
2022-2023 China Medical Device License-In/Out Project Core Clause Data Analysis
Article
23 Sep 2025
61款创新医疗器械获批：2023年度中国医疗器械注册工作报告亮点解读
Article
22 Sep 2025
Overview: 2022-2023 China Drug & Medical Device Annual Report
Article
22 Sep 2025
Top 10 Traps To Avoid: Navigating China's HGR Applications
Article
19 Sep 2025
Insights Into China Biotech's New Approach: Spin-Off-NewCo Model
Article
18 Sep 2025
观点 | 《医疗器械管理法（草案）》十大亮点快评
Article
18 Sep 2025
China Released Draft Medical Device Law For Comments
Article
18 Sep 2025
Key Takeaways on China's Pilot Plan for Segmented Production of Biological Products
Article
18 Sep 2025
China Pilots Lifting Restrictions On Foreign Investment In Stem Cell, Gene Therapy, And Genetic Diagnosis Sectors In Four Free Trade Zones
Article
16 Sep 2025
速评《美国优先投资政策备忘录》对中国生物医药行业的潜在影响
Article
12 Sep 2025
解读人类遗传资源管理最新问答：人源细胞系、肿瘤异种移植模型（CDX/PDX）、CAR-T治疗材料监管问题
Article
29 Aug 2025
Six Key Insights Into China Biotech's NewCo Model
Article
04 Apr 2025
揭秘中国创新药企NewCo模式实战中的"六脉神剑"
Article
02 Dec 2022
Overview Of China Drug Review Annual Report (2015-2021)
Article
25 Nov 2022
人遗相关法规之《科学技术部行政处罚实施办法（征求意见稿）》重点快评
Article
22 Nov 2022
Highlights On The New HGR-Related Administrative Penalty Rule
